Background: Surgical treatment of intracerebral haemorrhage (ICH) is unproven, although meta-analyses suggest that both early conventional surgery with craniotomy, and minimally-invasive surgery (MIS) may be beneficial. We aimed to demonstrate the safety, feasibility and promise of efficacy of early MIS for ICH using the Aurora Surgiscope and Evacuator.
Methods: We performed a prospective, single-arm phase IIa Simon’s Two-Stage design study at two stroke centres (10 patients with supratentorial ICH volumes ≥20mL and NIHSS≥6, surgery commencing <12 hours post-onset). Positive outcome was defined as ≥50% 24-hour ICH volume reduction, with the safety outcome lack of significant ICH reaccumulation.
Results: From December 2019-July 2020 we enrolled 10 patients at two Australian Comprehensive Stroke Centres, median age 70 (interquartile range(IQR) 65-74), National Institute of Health Stroke Scale(NIHSS) score 19(IQR 19-29), ICH volume 59mL(IQR 25-77), at a median 227 minutes(IQR 175-377) post-onset. MIS was commenced at a median 531 minutes(IQR 437-628) post-onset, was of 98 minutes median duration(IQR 77-110) with median immediate post-operative haematoma evacuation of 70%(IQR 67-80%).
A positive outcome was achieved in 5/5 first-stage patients and in 4/5 second-stage patients. One patient developed significant 24-hour ICH reaccumulation; otherwise 24-hour stability was observed (median reduction 71%(IQR 61-80), 5/9 patients <15mL residual)).
Three patients died, unrelated to surgery. There were no surgical safety concerns. At six months the median modified Rankin score was 4(IQR 3-6) with 30% achieving mRS 0-3.
Conclusion: Early ICH MIS using the Aurora Surgiscope and Evacuator appears feasible and safe, warranting further exploration.